We are exploring a new treatment using eftilagimod alpha for patients with advanced solid tumors. The study looks at its safety and how it works with other therapies.
Health conditions and diseases that the clinical trial is designed to study and treat.
Non-Small Cell Lung Cancer (NSCLC) is a type of lung cancer that is not small cell in nature, often characterized by slower growth compared to small cell lung cancer. It includes various subtypes, such as adenocarcinoma, and is typically treated with chemotherapy and immunotherapy.
Urothelial carcinoma is a type of cancer that occurs in the urothelium, the tissue lining the bladder and other parts of the urinary tract. It can be aggressive and is often treated with surgery, chemotherapy, or immunotherapy.
A malignant solid tumor is a mass of cancer cells that can invade nearby tissues and spread to other parts of the body. These tumors can occur in various organs and require aggressive treatment.
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.